Chemomab Therapeutics Ltd. — All Filings
336 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
15-15D
20-F
20-F/A
3
4
424B3
424B4
424B5
425
6-K
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
F-3/A
F-4
F-4/A
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | 6-K | 0001178913-23-003602 | Nov 9, 2023 | — |
| EFFECT | — | 9999999995-23-003187 | Nov 3, 2023 | — |
| CORRESP | — | 0001178913-23-003502 | Nov 1, 2023 | — |
| F-3/A | F-3/A | 0001178913-23-003439 | Oct 30, 2023 | — |
| F-3 | F-3 | 0001178913-23-003334 | Oct 16, 2023 | — |
| 6-K | 6-K | 0001178913-23-002860 | Aug 14, 2023 | Jun 30, 2023 |
| 6-K | 6-K | 0001178913-23-002732 | Aug 8, 2023 | — |
| 4 | — | 0001178913-23-002370 | Jul 5, 2023 | Jun 14, 2023 |
| 6-K | 6-K | 0001178913-23-002362 | Jul 3, 2023 | — |
| 4 | — | 0001178913-23-002235 | Jun 20, 2023 | Jun 16, 2023 |
| 8-K | 8-K | 0001178913-23-002225 | Jun 16, 2023 | Jun 14, 2023 |
| 4 | — | 0001178913-23-002227 | Jun 16, 2023 | Jun 14, 2023 |
| 3 | — | 0001178913-23-002162 | Jun 5, 2023 | Jun 1, 2023 |
| 8-K | 8-K | 0001178913-23-002136 | Jun 5, 2023 | Jun 1, 2023 |
| RW | RW | 0001178913-23-002125 | Jun 2, 2023 | — |
| S-1/A | S-1/A | 0001178913-23-001964 | May 19, 2023 | — |
| 10-Q | 10-Q | 0001178913-23-001807 | May 11, 2023 | Mar 31, 2023 |
| 8-K | 8-K | 0001178913-23-001809 | May 11, 2023 | — |
| 4 | — | 0001178913-23-001115 | Mar 23, 2023 | Mar 16, 2023 |
| 4 | — | 0001178913-23-001109 | Mar 23, 2023 | Mar 16, 2023 |
| 4 | — | 0001178913-23-001111 | Mar 23, 2023 | Mar 16, 2023 |
| 4 | — | 0001178913-23-001113 | Mar 23, 2023 | Mar 16, 2023 |
| S-1/A | S-1/A | 0001178913-23-001101 | Mar 22, 2023 | — |
| ARS | ARS | 0001178913-23-001067 | Mar 21, 2023 | Dec 31, 2022 |
| S-1/A | S-1/A | 0001178913-23-001080 | Mar 21, 2023 | — |
| 10-K | 10-K | 0001178913-23-001041 | Mar 20, 2023 | Dec 31, 2022 |
| S-1/A | S-1/A | 0001178913-23-000694 | Feb 22, 2023 | — |
| 8-K | 8-K | 0001178913-23-000679 | Feb 21, 2023 | — |
| 8-K | 8-K | 0001178913-23-000670 | Feb 21, 2023 | Dec 31, 2022 |
| S-1/A | S-1/A | 0001178913-23-000672 | Feb 21, 2023 | — |
| S-1 | S-1 | 0001178913-23-000164 | Jan 13, 2023 | — |
| 8-K | 8-K | 0001178913-23-000147 | Jan 11, 2023 | — |
| 4 | — | 0000947871-23-000015 | Jan 5, 2023 | Jan 3, 2023 |
| 4 | — | 0001178913-23-000076 | Jan 5, 2023 | Jan 3, 2023 |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-23-000013 | Jan 5, 2023 | — |
| 8-K | 8-K | 0001178913-23-000010 | Jan 3, 2023 | — |
| 8-K/A | 8-K/A | 0001178913-22-004189 | Nov 29, 2022 | Nov 14, 2022 |
| 4 | — | 0001178913-22-004100 | Nov 18, 2022 | Nov 16, 2022 |
| 4 | — | 0001178913-22-004098 | Nov 17, 2022 | Nov 16, 2022 |
| SC 13D/A | SC 13D/A | 0001178913-22-004096 | Nov 17, 2022 | — |
| 8-K | 8-K | 0001178913-22-004061 | Nov 16, 2022 | — |
| 3 | — | 0001178913-22-004049 | Nov 15, 2022 | Nov 14, 2022 |
| 8-K | 8-K | 0001178913-22-004019 | Nov 14, 2022 | — |
| 10-Q | 10-Q | 0001178913-22-003931 | Nov 10, 2022 | Sep 30, 2022 |
| S-8 | S-8 | 0001178913-22-003108 | Aug 15, 2022 | — |
| 8-K | 8-K | 0001178913-22-003072 | Aug 12, 2022 | — |
| 10-Q | 10-Q | 0001178913-22-003074 | Aug 12, 2022 | Jun 30, 2022 |
| 4 | — | 0001178913-22-002402 | Jun 21, 2022 | Mar 16, 2022 |
| 8-K | 8-K | 0001178913-22-002410 | Jun 21, 2022 | — |
| 3 | — | 0001178913-22-002412 | Jun 21, 2022 | Jun 16, 2022 |